A Clinical study of Siddha medicine Naaga sangu parpam and nattai parpam in the treatment of kuruthi moolam(Bleeding piles)

A Comparative Clinical study on Rattha moolam(Bleeding Piles) and the druge of choice is Naaga Sangu Parpam and Nattai Parpam

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012580

Enrollment

Registered

2018-03-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- RATTHA MOOLAM(Bleeding piles)

Interventions

Intervention1: Naaga sangu parpam(Internal) and Nattai parpam(Internal): Drug I-130 mg of Naaga sangu parpam administered oraly twice a day for the period of 24 days.DrugII-300 mg of Nattai parpam adm

Eligibility

Inclusion criteria

Inclusion criteria: Symptoms 1.Age: 20- 60Yrs hj 2.Sex â?? Both male and female 3.Patients who will be having classical symptoms of bleeding piles(1st degree internal haemorrhoids,constipation,Bleeding per anus,Itching in the perianal region.) 4.Willing to give blood samples for the investigation required. 5.Patient willing to sign the informed consent stating that he/she will conscientiously stick to the treatment during 24days but can opt out of the trial of his/her own conscious discretion.

Exclusion criteria

Exclusion criteria: 1.Patient having 2nd ,3rd degree internal haemorrhoids 2.Pregnancy and lactation 3.Fissure in ano 4.External haemorrhoids 5.Fistula in ano 6.Diabetes mellitus 7.Hypertension 8.Rectal tuberculosis 9.Rectal cancer

Design outcomes

Primary

Measure	Time frame
Reduction of pain and bleeding. Relieving of constipationTimepoint: 1 month	—

Secondary

Measure	Time frame
Reduced pile mass size. Timepoint: PRE STUDY SCREENING AND AFTER TREATMENT	—

Countries

India

Contacts

Public ContactDR H VETHA MERLIN KUMARI

NATIONAL INSTITUTE OF SIDDHA

drmohan139@gmail.com044-22411611

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026